Exosomes as a potential novel therapeutic tools against neurodegenerative diseases

Pharmacological Research

Volumn 113, Issue , 2016, Pages 816-822

  Jarmalavičiūtė, Akvilė ^a   Pivoriūnas, Augustas ^a  

^a State Research Institute Centre for Innovative Medicine   (Lithuania)

Author keywords

Blood brain barrier; Exosomes; Neurodegeneration; Neuroprotection

Indexed keywords

BIOACCUMULATION; BLOOD BRAIN BARRIER; CELL FUNCTION; DEGENERATIVE DISEASE; DENDRITIC CELL; DISEASE ASSOCIATION; EXOSOME; HUMAN; MESENCHYMAL STEM CELL; MOLECULAR DYNAMICS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; ANIMAL; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

NEUROPROTECTIVE AGENT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; EXOSOMES; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS;

EID: 84957665218     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.02.002     Document Type: Review

References (67)

1. [1] Lindvall, O., Barker, R.A., Brustle, O., Isacson, O., Svendsen, C.N., Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell 10 (2012), 151–155.
2. [2] Chinchalongporn, V., Koppensteiner, P., Pre, D., Thangnipon, W., Bilo, L., Arancio, O., Connectivity and circuitry in a dish versus in a brain. Alzheimers Res. Ther., 7, 2015, 44.
3. [3] Ela, S., Mager, I., Breakefield, X.O., Wood, M.J., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12 (2013), 347–357.
4. [4] Raposo, G., Stoorvogel, W., Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200 (2013), 373–383.
5. [5] Aryani, A., Denecke, B., Exosomes as a nanodelivery system: a key to the future of neuromedicine?. Mol. Neurobiol., 2014, 1–17, 10.1007/s12035-014-9054-5 First online: 15 December 2014 http://link.springer.com/article/10.1007%2Fs12035-014-9054-5.
6. [6] Pegtel, D.M., Peferoen, L., Amor, S., Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2014, 369.
7. [7] Gupta, A., Pulliam, L., Exosomes as mediators of neuroinflammation. J. Neuroinflammation, 11, 2014, 68.
8. [8] Hoshino, A., Costa-Silva, B., Shen, T.L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., Singh, S., Williams, C., Soplop, N., Uryu, K., Pharmer, L., King, T., Bojmar, L., Davies, A.E., Ararso, Y., Zhang, T., Zhang, H., Hernandez, J., Weiss, J.M., Dumont-Cole, V.D., Kramer, K., Wexler, L.H., Narendran, A., Schwartz, G.K., Healey, J.H., Sandstrom, P., Labori, K. Jorgen, Kure, E.H., Grandgenett, P.M., Hollingsworth, M.A., de Sousa, M., Kaur, S., Jain, M., Mallya, K., Batra, S.K., Jarnagin, W.R., Brady, M.S., Fodstad, O., Muller, V., Pantel, K., Minn, A.J., Bissell, M.J., Garcia, B.A., Kang, Y., Rajasekhar, V.K., Ghajar, C.M., Matei, I., Peinado, H., Bromberg, J., Lyden, D., Tumor exosome integrins determine organotropic metastasis. Nature 527 (2015), 329–335.
9. [9] Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of sirna to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29 (2011), 341–345.
10. [10] Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., Marshak, D.R., Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999), 143–147.
11. [11] da Silva Meirelles, L., Caplan, A.I., Nardi, N.B., In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26 (2008), 2287–2299.
12. [12] Bianco, P., “Mesenchymal” stem cells. Annu. Rev. Cell Dev. Biol. 30 (2014), 677–704.
13. [13] Bianco, P., Cao, X., Frenette, P., Mao, J., Robey, P., Simmons, P., Wang, C.-Y., The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19 (2013), 35–42.
14. [14] Kuznetsov, S.A., Krebsbach, P.H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., Robey, P.G., Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12 (1997), 1335–1347.
15. [15] Batouli, S., Miura, M., Brahim, J., Tsutsui, T.W., Fisher, L.W., Gronthos, S., Robey, P.G., Shi, S., Comparison of stem-cell-mediated osteogenesis and dentinogenesis. J. Dent. Res., 2003, 82.
16. [16] Huang, G.T.J., Gronthos, S., Shi, S., Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J. Dent. Res., 2009, 88.
17. [17] Kaukua, N., Shahidi, M.K., Konstantinidou, C., Dyachuk, V., Kaucka, M., Furlan, A., An, Z., Wang, L., Hultman, I., Ahrlund-Richter, L., Blom, H., Brismar, H., Lopes, N.A., Pachnis, V., Suter, U., Clevers, H., Thesleff, I., Sharpe, P., Ernfors, P., Fried, K., Adameyko, I., Glial origin of mesenchymal stem cells in a tooth model system. Nature 513 (2014), 551–554.
18. [18] Jarmalaviciute, A., Tunaitis, V., Strainiene, E., Aldonyte, R., Ramanavicius, A., Venalis, A., Magnusson, K.E., Pivoriunas, A., A new experimental model for neuronal and glial differentiation using stem cells derived from human exfoliated deciduous teeth. J. Mol. Neurosci. 238:1 (2013), 120–132.
19. [19] Király, M., Porcsalmy, B., Pataki, A., Kádár, K., Jelitai, M., Molnár, B., Hermann, P., Gera, I., Grimm, W.-D., Ganss, B., Zsembery, A., Varga, G., Simultaneous pkc and camp activation induces differentiation of human dental pulp stem cells into functionally active neurons. Neurochem. Int. 55 (2009), 323–355.
20. [20] Arthur, A., Rychkov, G., Shi, S., Koblar, S., Gronthos, S., Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells (Dayton, Ohio) 26 (2008), 1787–1795.
21. [21] Sakai, K., Yamamoto, A., Matsubara, K., Nakamura, S., Naruse, M., Yamagata, M., Sakamoto, K., Tauchi, R., Wakao, N., Imagama, S., Hibi, H., Kadomatsu, K., Ishiguro, N., Ueda, M., Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J. Clin. Invest. 122 (2012), 80–90.
22. [22] Nosrat, I., Widenfalk, J., Olson, L., Nosrat, C., Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury. Dev. Biol. 238 (2001), 120–132.
23. [23] Nosrat, I., Smith, C., Mullally, P., Olson, L., Nosrat, C., Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system. Eur. J. Neurosci. 19 (2004), 2388–2398.
24. [24] Fujii, H., Matsubara, K., Sakai, K., Ito, M., Ohno, K., Ueda, M., Yamamoto, A., Dopaminergic differentiation of stem cells from human deciduous teeth and their therapeutic benefits for parkinsonian rats. Brain Res. 1613 (2015), 59–72.
25. [25] Jarmalaviciute, A., Tunaitis, V., Pivoraite, U., Venalis, A., Pivoriunas, A., Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine-induced apoptosis. Cytotherapy 17 (2015), 932–939.
26. [26] Mazzio, E., Reams, R., Soliman, K., The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro. Brain Res. 1004 (2004), 29–44.
27. [27] Zhou, Y., Xu, H., Xu, W., Wang, B., Wu, H., Tao, Y., Zhang, B., Wang, M., Mao, F., Yan, Y., Gao, S., Gu, H., Zhu, W., Qian, H., Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res. Ther., 4, 2013, 34.
28. [28] Sreekumar, P.G., Kannan, R., Kitamura, M., Spee, C., Barron, E., Ryan, S.J., Hinton, D.R., Αb crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells. PLoS One, 5, 2010, e12578.
29. [29] Haney, M.J., Klyachko, N.L., Zhao, Y., Gupta, R., Plotnikova, E.G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A.V., Batrakova, E.V., Exosomes as drug delivery vehicles for Parkinson's disease therapy. J. Control. Release 207 (2015), 18–30.
30. [30] Katsuda, T., Tsuchiya, R., Kosaka, N., Yoshioka, Y., Takagaki, K., Oki, K., Takeshita, F., Sakai, Y., Kuroda, M., Ochiya, T., Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci. Rep., 3, 2013, 1197.
31. [31] Miners, J.S., Barua, N., Kehoe, P.G., Gill, S., Love, S., Abeta-degrading enzymes: potential for treatment of alzheimer disease. J. Neuropathol. Exp. Neurol. 70 (2011), 944–959.
32. [32] Farinazzo, A., Turano, E., Marconi, S., Bistaffa, E., Bazzoli, E., Bonetti, B., Murine adipose-derived mesenchymal stromal cell vesicles: in vitro clues for neuroprotective and neuroregenerative approaches. Cytotherapy 17 (2015), 571–578.
33. [33] Bonafede, R., Scambi, I., Peroni, D., Potrich, V., Boschi, F., Benati, D., Bonetti, B., Mariotti, R., Exosome derived from murine adipose-derived stromal cells: neuroprotective effect onin vitromodel of amyotrophic lateral sclerosis. Exp. Cell Res., 2015.
34. [34] Kordelas, L., Rebmann, V., Ludwig, A.K., Radtke, S., Ruesing, J., Doeppner, T.R., Epple, M., Horn, P.A., Beelen, D.W., Giebel, B., Msc-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28 (2014), 970–973.
35. [35] Doeppner, T.R., Herz, J., Gorgens, A., Schlechter, J., Ludwig, A.K., Radtke, S., de Miroschedji, K., Horn, P.A., Giebel, B., Hermann, D.M., Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl. Med. 4 (2015), 1131–1143.
36. [36] Xin, H., Li, Y., Cui, Y., Yang, J.J., Zhang, Z.G., Chopp, M., Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab. 33 (2013), 1711–1715.
37. [37] Zhang, Y., Chopp, M., Meng, Y., Katakowski, M., Xin, H., Mahmood, A., Xiong, Y., Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J. Neurosurg. 122 (2015), 856–867.
38. [38] Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., Shang, X., Zhang, Z.G., Chopp, M., Exosome-mediated transfer of mir-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30 (2012), 1556–1564.
39. [39] Kim, J., Inoue, K., Ishii, J., Vanti, W.B., Voronov, S.V., Murchison, E., Hannon, G., Abeliovich, A., A microrna feedback circuit in midbrain dopamine neurons. Science 317 (2007), 1220–1224.
40. [40] Li, T., Yan, Y., Wang, B., Qian, H., Zhang, X., Shen, L., Wang, M., Zhou, Y., Zhu, W., Li, W., Xu, W., Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 22 (2013), 845–854.
41. [41] Tan, K.Y., Teo, K.L., Lim, J.F., Chen, A.K., Reuveny, S., Oh, S.K., Serum-free media formulations are cell line-specific and require optimization for microcarrier culture. Cytotherapy 17 (2015), 1152–1165.
42. [42] Bernardo, M.E., Fibbe, W.E., Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13 (2013), 392–402.
43. [43] Zhang, B., Yin, Y., Lai, R.C., Lim, S.K., Immunotherapeutic potential of extracellular vesicles. Front Immunol., 5, 2014, 518.
44. [44] Segura, E., Nicco, C., Lombard, B., Veron, P., Raposo, G., Batteux, F., Amigorena, S., Thery, C., Icam-1 on exosomes from mature dendritic cells is critical for efficient naive t-cell priming. Blood 106 (2005), 216–223.
45. [45] Montecalvo, A., Larregina, A.T., Shufesky, W.J., Stolz, D.B., Sullivan, M.L., Karlsson, J.M., Baty, C.J., Gibson, G.A., Erdos, G., Wang, Z., Milosevic, J., Tkacheva, O.A., Divito, S.J., Jordan, R., Lyons-Weiler, J., Watkins, S.C., Morelli, A.E., Mechanism of transfer of functional micrornas between mouse dendritic cells via exosomes. Blood 119 (2012), 756–766.
46. [46] Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S., Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4 (1998), 594–600.
47. [47] Viaud, S., Thery, C., Ploix, S., Tursz, T., Lapierre, V., Lantz, O., Zitvogel, L., Chaput, N., Dendritic cell-derived exosomes for cancer immunotherapy: what's next?. Cancer Res. 70 (2010), 1281–1285.
48. [48] Pusic, A.D., Pusic, K.M., Clayton, B.L., Kraig, R.P., Ifngamma-stimulated dendritic cell exosomes as a potential therapeutic for remyelination. J. Neuroimmunol. 266 (2014), 12–23.
49. [49] Shin, D., Shin, J.Y., McManus, M.T., Ptacek, L.J., Fu, Y.H., Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann. Neurol. 66 (2009), 843–857.
50. [50] Pusic, A.D., Kraig, R.P., Youth and environmental enrichment generate serum exosomes containing mir-219 that promote cns myelination. Glia 62 (2014), 284–299.
51. [51] Hu, G.W., Li, Q., Niu, X., Hu, B., Liu, J., Zhou, S.M., Guo, S.C., Lang, H.L., Zhang, C.Q., Wang, Y., Deng, Z.F., Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res. Ther., 6, 2015, 10.
52. [52] Wang, Y., Zhang, L., Li, Y., Chen, L., Wang, X., Guo, W., Zhang, X., Qin, G., He, S.H., Zimmerman, A., Liu, Y., Kim, I.M., Weintraub, N.L., Tang, Y., Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective mirnas and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int. J. Cardiol. 192 (2015), 61–69.
53. [53] Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M., Herrup, K., Frautschy, S.A., Finsen, B., Brown, G.C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G.C., Town, T., Morgan, D., Shinohara, M.L., Perry, V.H., Holmes, C., Bazan, N.G., Brooks, D.J., Hunot, S., Joseph, B., Deigendesch, N., Garaschuk, O., Boddeke, E., Dinarello, C.A., Breitner, J.C., Cole, G.M., Golenbock, D.T., Kummer, M.P., Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14 (2015), 388–405.
54. [54] Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R.C., Ju, S., Mu, J., Zhang, L., Steinman, L., Miller, D., Zhang, H.G., Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19 (2011), 1769–1779.
55. [55] Armulik, A., Genove, G., Mae, M., Nisancioglu, M.H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., Johansson, B.R., Betsholtz, C., Pericytes regulate the blood–brain barrier. Nature 468 (2010), 557–561.
56. [56] Pardridge, W.M., Blood–brain barrier endogenous transporters as therapeutic targets: a new model for small molecule cns drug discovery. Expert. Opin. Ther. Targets 19 (2015), 1059–1072.
57. [57] Chow, B.W., Gu, C., The molecular constituents of the blood–brain barrier. Trends Neurosci. 38 (2015), 598–608.
58. [58] Record, M., Subra, C., Silvente-Poirot, S., Poirot, M., Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 81 (2011), 1171–1182.
59. [59] Zhou, W., Fong, M.Y., Min, Y., Somlo, G., Liu, L., Palomares, M.R., Yu, Y., Chow, A., O'Connor, S.T., Chin, A.R., Yen, Y., Wang, Y., Marcusson, E.G., Chu, P., Wu, J., Wu, X., Li, A.X., Li, Z., Gao, H., Ren, X., Boldin, M.P., Lin, P.C., Wang, S.E., Cancer-secreted mir-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25 (2014), 501–515.
60. [60] Tominaga, N., Kosaka, N., Ono, M., Katsuda, T., Yoshioka, Y., Tamura, K., Lotvall, J., Nakagama, H., Ochiya, T., Brain metastatic cancer cells release microrna-181c-containing extracellular vesicles capable of destructing blood–brain barrier. Nat. Commun., 6, 2015, 6716.
61. [61] Abdelnaby, K., Leila, K.-G., Maria Luz, A.-A., Joaquin, T.-S., David, G., Plasma-derived exosomes alter endothelial tight junction in obese children with obstructive sleep apnea: effect of adenotonsillectomy (t&a) B26 pediatric sleep: from the heart to the brain. Am. Thorac. Soc., 2015 A2596–A2596.
62. [62] Strazza, M., Pirrone, V., Wigdahl, B., Nonnemacher, M.R., Breaking down the barrier: the effects of hiv-1 on the blood–brain barrier. Brain Res. 1399 (2011), 96–115.
63. [63] Raymond, A.D., Diaz, P., Chevelon, S., Agudelo, M., Yndart-Arias, A., Ding, H., Kaushik, A., Jayant, R.D., Nikkhah-Moshaie, R., Roy, U., Pilakka-Kanthikeel, S., Nair, M.P., Microglia-derived hiv nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of nef peptides. J. Neurovirol., 2015.
64. [64] Madison, M.N., Okeoma, C.M., Exosomes: implications in hiv-1 pathogenesis. Viruses 7 (2015), 4093–4118.
65. [65] Gould, S.J., Booth, A.M., Hildreth, J.E., The trojan exosome hypothesis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 10592–10597.
66. [66] Cooper, J.M., Wiklander, P.B., Nordin, J.Z., Al-Shawi, R., Wood, M.J., Vithlani, M., Schapira, A.H., Simons, J.P., El-Andaloussi, S., Alvarez-Erviti, L., Systemic exosomal sirna delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov. Disord. 29 (2014), 1476–1485.
67. [67] Pivoraite, U., Jarmalaviciute, A., Tunaitis, V., Ramanauskaite, G., Vaitkuviene, A., Kaseta, V., Biziuleviciene, G., Venalis, A., Pivoriunas, A., Exosomes from human dental pulp stem cells suppress carrageenan-induced acute inflammation in mice. Inflammation 38 (2015), 1933––1941.